Security key
89680M101
TriSalus Life Sciences, Inc. - Common Stock, Par Value $0.0001 per share (TLSI)
CUSIP: 89680M101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, Par Value $0.0001 per share
- Shares outstanding
- 61,321,365
- Total 13F shares
- 8,470,104
- Share change
- +5,519,321
- Total reported value
- $46,161,422
- Price per share
- $5.45
- Number of holders
- 46
- Value change
- +$30,072,898
- Number of buys
- 36
- Number of sells
- 10
Report period
Q2 2025
Institutions
46
Top holders
10
TLSI full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
TriSalus Life Sciences, Inc. SEC filings
TriSalus Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89680M101
Recent filing periods:
Top shareholders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, Par Value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.3%
|
827,357
|
$4,567,011 | — | 31 Mar 2025 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
1%
|
643,740
|
$3,553,445 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.79%
|
486,618
|
$2,686,132 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
219,424
|
$1,211,554 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
133,380
|
$736,258 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
65,000
|
$358,800 | — | 31 Mar 2025 | |
| MSD Partners, L.P. |
13F
|
Company |
0.07%
|
39,999
|
$220,794 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
39,926
|
$220,392 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
33,900
|
$187,128 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.05%
|
30,270
|
$167,090 | — | 31 Mar 2025 | |
| Connective Capital Management, LLC |
13F
|
Company |
0.05%
|
29,079
|
$160,516 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
26,580
|
$146,722 | — | 31 Mar 2025 | |
| Connecticut Wealth Management, LLC |
13F
|
Company |
0.04%
|
22,303
|
$123,113 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
20,200
|
$111,504 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
20,200
|
$111,504 | — | 31 Mar 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
15,554
|
$86,000 | — | 31 Mar 2025 | |
| Lido Advisors, LLC |
13F
|
Company |
0.02%
|
14,197
|
$78,367 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
13,657
|
$75,000 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
10,804
|
$59,638 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
10,596
|
$58,490 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
10,000
|
$55,200 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
10,000
|
$55,200 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,809
|
$37,586 | — | 31 Mar 2025 | |
| Arax Advisory Partners |
13F
|
Company |
0.01%
|
4,008
|
$22,125 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,361
|
$13,033 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,001
|
$5,526 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
958
|
$5,288 | — | 31 Mar 2025 | |
| Richard Charles Hoertkorn |
13F
|
Individual |
0%
|
668
|
$3,687 | — | 31 Mar 2025 | |
| COLDSTREAM CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
150
|
$828 | — | 31 Mar 2025 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
100
|
$552 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
32
|
$177 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
21
|
$116 | — | 31 Mar 2025 | |
| MedTech Acquisition Sponsor LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,250,000
mixed-class rows
|
$65,538,115 | — | 26 Jun 2023 | |
| Magnetar Financial LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
16,668
|
$174,782 | — | 12 Jun 2023 | |
| Sean Murphy |
3/4/5
|
Director |
—
mixed-class rows
|
1,308,937
mixed-class rows
|
$3,818,390 | — | 12 Jun 2025 | |
| George Kelly Martin |
3/4/5
|
Director |
—
mixed-class rows
|
262,176
mixed-class rows
|
$1,359,468 | — | 28 Aug 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
185,708
mixed-class rows
|
$1,024,341 | — | 31 Mar 2025 | |
| Graypoint LLC |
13F
|
Company |
—
class O/S missing
|
827,590
|
$960,004 | — | 31 Mar 2025 | |
| Arjun Jj Desai |
3/4/5
|
Director |
—
mixed-class rows
|
312,127
mixed-class rows
|
$911,899 | — | 12 Jun 2025 | |
| James Alecxih |
3/4/5
|
President, Device Technology |
—
class O/S missing
|
94,754
|
$521,147 | — | 10 Aug 2023 | |
| James Emmett Young |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
154,663
mixed-class rows
|
$428,854 | — | 19 May 2025 | |
| Steven C. Katz |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
173,587
mixed-class rows
|
$377,229 | — | 12 Feb 2024 | |
| Vestcor Inc |
13F
|
Company |
—
mixed-class rows
|
94,208
mixed-class rows
|
$232,000 | — | 31 Mar 2025 | |
| Liselotte Hyveled |
3/4/5
|
Director |
—
mixed-class rows
|
60,040
mixed-class rows
|
$39,859 | — | 02 Jan 2025 | |
| B & T Capital Management DBA Alpha Capital Management |
13F
|
Company |
—
class O/S missing
|
22,222
|
$25,778 | — | 31 Mar 2025 | |
| Foster Victor Wealth Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
12,601
|
$14,617 | — | 31 Mar 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
8,735
|
$10,569 | — | 31 Mar 2025 | |
| Andrew C. von Eschenbach |
3/4/5
|
Director |
—
mixed-class rows
|
50,000
mixed-class rows
|
— | — | 13 Aug 2024 | |
| Anil K. Singhal |
3/4/5
|
Director |
—
class O/S missing
|
15,000
|
— | — | 13 Aug 2024 |
Institutional Holders of TriSalus Life Sciences, Inc. - Common Stock, Par Value $0.0001 per share (TLSI) as of Q2 2025
As of 30 Jun 2025,
TriSalus Life Sciences, Inc. - Common Stock, Par Value $0.0001 per share (TLSI) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,470,104 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, AWM Investment Company, Inc., GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, Wealthcare Advisory Partners LLC, BlackRock, Inc., Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, and NORTHERN TRUST CORP.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
33
Q2 2025 holders
46
Holder diff
13
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.